Results 181 to 190 of about 3,018 (199)

Relapse free survival in a prospective cohort of hormone receptor/Her2neu defined breast cancer patients

Journal of Clinical Oncology, 2007
21003 Background: Adjuvant trastuzumab for Her2/neu (Her2) positive breast cancer (BC) is now standard treatment. We describe hormone receptor (HR)/Her2/neu defined phenotypic BC subgroups and evaluate recurrence risk prior to widespread use of adjuvant trastuzumab.
H. G. Kaplan, J. A. Malmgren, M. K. Atwood   +2 more
openaire   +1 more source

An evaluation of the societal costs and benefits of adjuvant trastuzumab in the treatment of early HER2neu-positive breast cancer in Singapore.

Journal of Clinical Oncology, 2010
e16514 Background: Adjuvant trastuzumab improves disease-free and overall survival in the treatment of patients with early Her2neu- positive breast cancer.
openaire   +1 more source

Association between ER and HER2neu status with various sonographic findings in breast cancer

Karbala Journal of Medicine
Diagnostic ultrasonography  is often  used as a  radiological modality  for assessing  clinically  or radiologically  suspected mammary  lesions based on certain radiological  criteria. This study was conducted to investigate an association between breast sonographic findings and biological markers (ER and HER2\NEU). The study enrolled 100 histological
openaire   +1 more source

TOP2A and HER2neu Evaluation in Malignant Pleural Mesothelioma

C110. THE FUTURE OF LUNG CANCER BIOMARKERS: WHERE SHOULD WE LOOK?, 2019
F.M.A. Abou Elkasem, M. Rahouma, I. Loay, O. Badawi, M. Kamel, D.A. Ibrahim, G. Ghaly, M. Amin, A.M. Abdelrahman   +8 more
openaire   +1 more source

PROGNOSIS OF MODIFIED NOTTINGHAM PROGNOSTIC INDEX IN RELATION TO AGE, ER, PR, HER2NEU AND KI67

European Journal of Clinical Pharmacy
Objectives: To determine the grading of the Modified Nottingham Prognostic Index (MNPI) among patients with breast cancer and to compare the frequency of ER, PR, HER2neu, and Ki67 expression between patients with good, moderate, and poor prognosis. Study Design and Setting: A cross-sectional study conducted in the Department of General Surgery, Liaquat
openaire   +1 more source

Genotypisierung Hormonrezeptor und HER2neu negativer Mammakarzinome (TNBC) von BRCA1-Mutationsträgerinnen

Geburtshilfe und Frauenheilkunde, 2018
RL Fröhlich, E Honisch, AS Vesper, I Beyer, M Rudelius, T Fehm, D Niederacher   +6 more
openaire   +1 more source

Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071)

Cancer Chemotherapy and Pharmacology, 2018
Annett Maderer, Thomas Thomaidis, István Lang   +2 more
exaly  

Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis

Gynecologic Oncology, 2004
Alexander Tsodikov, Mark Dodson
exaly  

Prognostic Value of Her2neu and EGFR in Primary Ovarian High Grade Serous Carcinoma.

Case Medical Research, 2020
openaire   +1 more source

Molecular Subtypes of Breast Cancer in South Asian Population by Immunohistochemical Profile and Her2neu Gene Amplification by FISH Technique: Association with other Clinicopathologic Parameters

Breast Journal, 2014
Atif Ali Hashmi, Muhammad Muzzammil Edhi, Naveen Faridi   +2 more
exaly